IPO comments on joint collaboration between USPTO and FDA on innovation and IP protection

Importance of considering intellectual assets during startup valuation in Brazil

Overview of challenges and strategies for patenting antibody-related inventions in Brazil

Discussion on ownership of IP rights in Brazil’s biomedical research and development

Detailed overview of post-grant opposition procedures for patents in Brazil

Update on preliminary injunctions in Brazil’s biotechnology and pharmaceutical patent litigation

Strategies for obtaining patents using post-filing experimental evidence in Brazil

Practical tips following Brazil’s impactful patent term decision

The Brazilian Supreme Court case that could reshape the country’s patent system

Examination of how COVID-19 has affected IP law and practice in Brazil

Brazil prepares to introduce regulations for cannabis-based pharmaceuticals

Risks associated with evolving biosimilar regulations and pharmacovigilance in Brazil

Legal implications and challenges of quantum computing and AI in Brazil

BRPTO introduces a new appeal stage workflow to improve patent examination, focusing on enhancing consistency and efficiency in Brazil’s patent appeal process

Brazilian Congress to debate whether AI can be recognized as an inventor in patents